Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of FC Gamma RIIIA Polymorphism and Thrombopoietin (THPO) Expression With Response to TPO Agonists in Refractory ITP and the Impact of Therapy on B and T Cells Subsets in the Patients With Mutated Genotypes

NCT02877212 is registered in ClinicalTrials.gov with National Institute of Blood and Marrow Transplant (NIBMT), Pakistan as lead sponsor.

NCT NCT02877212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02877212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of FC Gamma RIIIA Polymorphism and Thrombopoietin (THPO) Expression With Response to TPO Agonists in Refractory ITP and the Impact of Therapy on B and T Cells Subsets in the Patients With Mutated Genotypes
Lead sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2016
Completion date
September 30, 2017
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura (itp)